CRVO
CervoMed Inc.
NASDAQ: CRVO · HEALTHCARE · BIOTECHNOLOGY
$3.69
+1.10% today
Updated 2026-04-30
Market cap
$35.92M
P/E ratio
—
P/S ratio
8.97x
EPS (TTM)
$-2.98
Dividend yield
—
52W range
$4 – $12
Volume
0.1M
CervoMed Inc. (CRVO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-95,479.00%
ROE
-93.90%
ROA
-53.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-48096.00 | — | — | — |
| 2007 | $308761.00 | $-2.67M | 56.55% | -934.06% | -863.45% |
| 2008 | $40189.00 | $-2.09M | 38.59% | -5,528.88% | -5,207.89% |
| 2009 | — | $-3.40M | — | — | — |
| 2010 | $40189.00 | $-8.41M | -423.00% | -19,002.71% | -20,926.12% |
| 2011 | $570476.00 | $-22.64M | -304.66% | -2,879.88% | -3,967.91% |
| 2012 | $374542.00 | $-6.87M | 37.04% | -3,148.38% | -1,833.97% |
| 2013 | $71667.00 | $-2.46M | -842.79% | -11,039.95% | -3,438.12% |
| 2014 | — | $-14.35M | — | — | — |
| 2015 | — | $-6.72M | — | — | — |
| 2016 | — | $-18.04M | — | — | — |
| 2017 | — | $-1.36M | — | — | — |
| 2018 | — | $-18.37M | — | — | — |
| 2019 | $0.00 | $-11.80M | — | — | — |
| 2020 | $0.00 | $-14.19M | — | — | — |
| 2021 | $0.00 | $-24.10M | — | — | — |
| 2022 | $0.00 | $-15.59M | — | — | — |
| 2023 | $7.14M | $-2.17M | -18.11% | -109.35% | -30.40% |
| 2024 | $9.74M | $-16.29M | -93.04% | -187.18% | -167.29% |
| 2025 | $4.01M | $-26.97M | — | -706.22% | -673.06% |